Neurofibromatosis type 1, cognitive impairment, and attention deficit hyperactivity disorder - Commentary

Journal of the Canadian Academy of Child and Adolescent Psychiatry

Volumn 15, Issue 2, 2006, Pages 87-90

  Keyhan, Nicola ^a   Minden, Debbie ^a   Ickowicz, Abel ^a   Parkin, Patricia ^a,b,c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; CASE REPORT; COGNITIVE DEFECT; DEPRESSION; DISEASE ASSOCIATION; HELPLESSNESS; HUMAN; MALE; MEMORY DISORDER; MENTAL HEALTH CARE; MENTAL INSTABILITY; NEUROFIBROMATOSIS; NOTE; PSYCHIATRIC DIAGNOSIS; PSYCHIATRIST; PSYCHOEDUCATION; PSYCHOTHERAPY; RATING SCALE; SCHOOL CHILD; SOCIAL DISABILITY;

EID: 33744522666     PISSN: 12097268     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (15)

1. Beery, K.E. (1997). The Beery-Buktenica Developmental Test of Visual-Motor Integration, 4th Edition, Revised. Parsippany, NJ: Modern Curriculum Press.
2. Conners, C.K., Sitarenios, G., Parker, J.D. & Epstein, J.N. (1998). The revised Conners' Parent Rating Scale (CPRS-R): factor structure, reliability, and criterion validity. Journal of Abnormal Child Psychology, 26(4); 257-68.
3. Dilts, C.V., Carey, J.C., Kircher, J.C., Hoffman, R.O., Creel, D., Ward, K., Clark, E. & Leonard, C.O. (1996). Children and adolescents with neurofibromatosis 1: a behavioral phenotype. Developmental and Behavioral Pediatrics, 17(4), 229-239.
4. Gutmann, D.H. (2002). Neurofibromin in the brain. Journal of Child Neurology, 17(8), 592-601.
5. Kayl, A.E., Moore, B.D. 3rd, Slopis, J.M., Jackson, E.F. & Leeds, N.E. (2000). Quantitative morphology of the corpus collosum in children with neurofibromatosis and attention deficit hyperactivity disorder. Journal of Child Neurology, 15, 90-96.
6. Mautner, V.F., Kluwe, L., Thakker, S.D. & Leark, R.A. (2002). Treatment of ADHD in Neurofibromatosis type 1. Developmental Medicine & Child Neurology, 44, 164-70.
7. Mazzocco, M.M., Turner, J.E., Denckla, M.B., Hofman, K.J., Scanlon, D.C. & Vellutino, F.R. (1995). Language and reading deficits associated with neurofibromatosis type 1: evidence for a not-so-nonverbal learning disability. Developmental Neuropsychology, 11(4), 503-522.
8. Moore, B.D., Slopis, J.M., Schomer, D., Jackson, E.F. & Levy, B.M. (1996). Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis. Neurology, 46, 1660-1668.
9. North, K.N., Riccardi, V., Samango-Sprouse, C., Ferner, R., Moore, B.D. 3rd, Legius, E., Ratner, N. & Denckla, M.B. (1997). Cognitive function and academic performance in neurofibromatosis 1: consensus statement from the NF1 cognitive disorders task force. Neurology, 48, 1121-1127.
10. North, K., Hyman, S. & Barton, B. (2002). Cognitive deficits in neurofibromatosis 1. Journal of Child Neurology, 17(8), 605-612.
11. Schrimsher, G.W., Billingsley, R.L., Slopis, J.M. & Moore, B.D. 3rd. (2003). Visual-spatial performance deficits in children with neurofibromatosis type 1. American Journal of Medical Genetics, 120(3), 326-330.
12. Sheslow, D. & Adams, W. (1990). Wide Range Assessment of Memory and Learning. Wilmington, DE: Wide Range, Inc.
13. Wechsler, D. (1991). Wechsler Intelligence Scale for Children - Third Edition. San Antonio, TX: The Psychological Corporation.
14. Wechsler, D. (1992). Wechsler Individual Achievement Test. San Antonio, TX: The Psychological Corporation.
15. Wilkinson, G.S. (1993). The Wide Range Achievement Test. Wilmington, D. E: Wide Range Inc.